Magnetic Resonance Imaging in Predicting Pathological Response of Triple Negative Breast Cancer Following Neoadjuvant Chemotherapy
- 10 December 2007
- journal article
- other
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 25 (35) , 5667-5669
- https://doi.org/10.1200/jco.2007.14.6134
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Pathological Complete Response in Triple Negative Poorly Differentiated Invasive Ductal Breast Carcinoma Detected During PregnancyJournal of Clinical Oncology, 2007
- Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotypeCancer, 2007
- The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer SubtypesClinical Cancer Research, 2007
- Triple-negative breast cancer: therapeutic optionsThe Lancet Oncology, 2007
- Locoregional Relapse and Distant Metastasis in Conservatively Managed Triple Negative Early-Stage Breast CancerJournal of Clinical Oncology, 2006
- Prognostic markers in triple‐negative breast cancerCancer, 2006
- Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer StudyJAMA, 2006
- Pathological complete response and residual DCIS following neoadjuvant chemotherapy for breast carcinomaBritish Journal of Cancer, 2006
- Unargued issues on the pathological assessment of response in primary systemic therapy for breast cancerBiomedicine & Pharmacotherapy, 2005
- Breast Cancer Molecular Subtypes Respond Differently to Preoperative ChemotherapyClinical Cancer Research, 2005